Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

6Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Dinicolantonio, J. J., Barroso-Aranda, J., & McCarty, M. F. (2021, April 19). Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors. Open Heart. BMJ Publishing Group. https://doi.org/10.1136/openhrt-2021-001655

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free